Lung Cancer: Genomic Tests & Improved Outcomes
National Cancer Institute: Lung cancer is the leading cause of cancer death in men & women. Here's what you need to know
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.
Kris MG, et al. JAMA. 2014 May 21;311(19):1998-2006.
Kris MG, et al. JAMA. 2014 May 21;311(19):1998-2006.
Non–small cell lung cancer and precision medicine: A model for the incorporation of genomic features into clinical trial design
Pasche B, et al. JAMA 2014 May 12
Pasche B, et al. JAMA 2014 May 12
Personalized medicine boost lung cancer survival, Phillipa Brice, PHG Foundation, May 23
Phillipa Brice, PHG Foundation, May 23Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer: a systematic review and cost-effectiveness analysis
Westwood M, et al. Health Technol Assess 2014 May;18(32):1-166
Westwood M, et al. Health Technol Assess 2014 May;18(32):1-166
Find out which genomic tests for lung cancer can improve health and affect survival (tier 1),visit the CDC Table of genomic applications by level of evidence and look for lung cancer entries
.png)
No hay comentarios:
Publicar un comentario